ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,987Hybrid

Multiple Sclerosis Journal

Abbreviation (ISO):MULT SCLER
•
Identifier (ISSN):1352-4585(Print)/1477-0970(Online)
•
Publisher:SAGE Publications Ltd
Former Names:
MULT SCLER J
Clarivate JCR Index Advisory: Name Changed (Active in JCR)
Clarivate IF (2026)
4.1↓ -0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Multiple Sclerosis Journal

WoS Q1
24795.2820185.6520195.4120206.3120215.8620225.820234.82024520254.12026
Annual Impact Factor Metric
Current (2026):4.1
Scopus SJR & RankScopus Q1
1.68
#1,987

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
164

164 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate10.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
197articles/year
35.48% Gold OA•93.1% Original Research

Aims & Scope

Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. The journal for your research in the following areas: * __Biologic basis:__ pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics * __Epidemology and genetics:__ genetics epigenetics, epidemiology * __Clinical and Neuroimaging:__ clinical neurology, biomarkers, neuroimaging and clinical outcome measures * __Therapeutics and rehabilitation:__ therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management Print ISSN: 1352-4585

Topics Covered (Recognized by AI)
MedicineBiologyPsychologyPsychiatryImmunologyInternal MedicinePathologyNeuroscienceGeneticsPathology & DiseasesSurgeryChemistryRadiologyMathematicsBiochemistry
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CLINICAL NEUROLOGY

Q1
Rank65/296
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q2
Rank106/330
IndexSCIE
JCISCIE2026

CLINICAL NEUROLOGY

Q1
Rank64/296
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q2
Rank83/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.1
Articles / Year191
Total Citations60
2025
IF5
Articles / Year235
Total Citations623
2024
IF4.8
Articles / Year266
Total Citations1,700
2023
IF5.8
Articles / Year215
Total Citations2,393
2022
IF5.855
Articles / Year217
Total Citations3,270

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,987Scopus Q1SCImago Profile
Scopus Coverage:1995-2026
Scopus Broad Areas:MedicineNeuroscience
Scopus Citation Rank (SJR)Q1
1.68

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.51

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,704 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,802
3-Year Documents751
Citable Documents609

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

NeurologyQ1
Neurology (clinical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 10.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区CLINICAL NEUROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Multiple Sclerosis Journal (abbr: MULT SCLER, ISSN: 1352-4585) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Ltd in England since 1995. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.680 (Q1), an H-index of 164.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 197 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,704 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
SAGE Publications Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1995
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 402a204e-eacf-46eb-be1c-cca2ec1dde59
Database Updated: 2026-09-28